Circulating levels of butyrate are inversely related to portal hypertension, endotoxemia, and systemic inflammation in patients with cirrhosis.
Juanola O, Ferrusquía-Acosta J, García-Villalba R, Zapater P, Magaz M, Marín A, Olivas P, Baiges A, Bellot P, Turon F, Hernández-Gea V, González-Navajas JM, Tomás-Barberán FA, García-Pagán JC, Francés R.
Juanola O, et al.
FASEB J. 2019 Oct;33(10):11595-11605. doi: 10.1096/fj.201901327R. Epub 2019 Jul 25.
FASEB J. 2019.
PMID: 31345057
A global reduction in the blood levels of SCFA in patients with cirrhosis is associated with a more advanced liver disease, suggesting its contribution to disease progression.-Juanola, O., Ferrusquia-Acosta, J., Garcia-Villalba, R., Zapater, P., Magaz, M., Marin, A. …
A global reduction in the blood levels of SCFA in patients with cirrhosis is associated with a more advanced liver disease, suggesting its c …